MOLN
Molecular Partners AG
Price Chart
Latest Quote
$3.70
+0.11 (+3.06%)
Current Price
| Previous Close | $3.59 |
| Open | $3.65 |
| Day High | $3.70 |
| Day Low | $3.60 |
| Volume | 1,251 |
Stock Information
Note: Financial values converted from CHF to USD
| Shares Outstanding | 38.31M |
| Total Debt | $3.67M |
| Cash Equivalents | $81.98M |
| Net Income | $-61.77M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $141.73M |
| EPS (TTM) | $-1.71 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $72.63M |
| Income | $-61.77M |
| Book/sh | $1.85 |
| Cash/sh | $1.77 |
| Employees | 134 |
Financial Ratios
| Quick Ratio | 7.05 |
| Current Ratio | 7.27 |
| Debt/Eq | 5.20 |
Returns & Margins
| ROA | -32.27% |
| ROE | -61.97% |
Ownership
| Institutional Ownership | 9.38% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -22.42 |
| P/B | 2.00 |
Analyst Data
| Recommendation | none |
| Target Price | $10.43 |
Technical Indicators
| SMA20 | $3.74 |
| SMA50 | $4.05 |
| SMA200 | $4.18 |
| RSI | 43.54 |
| ATR | 0.1396 |
| Shares Float | 20.71M |
| Short Ratio | 0.22 |
| Volatility | 0.69 |
| Rel Volume | 0.63 |
Performance History
| Week | +0.00% |
| Month | -4.15% |
| Quarter | -5.85% |
| 6 Months | -13.55% |
| YTD | -12.32% |
| Year | +4.52% |
| 3 Years | -6.33% |
| 5 Years | -81.45% |
| 10 Years | -81.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $3.70 | 1,251 |
| 2026-10-26 | $3.59 | 1,600 |
| 2026-10-23 | $3.67 | 4,300 |
| 2026-10-22 | $3.61 | 3,500 |
| 2026-10-21 | $3.72 | 3,100 |
| 2026-10-20 | $3.70 | 2,600 |
| 2026-10-19 | $3.66 | 900 |
| 2026-10-16 | $3.56 | 700 |
| 2026-10-15 | $3.65 | 0 |
| 2026-10-14 | $3.65 | 3,300 |
| 2026-10-13 | $3.67 | 1,400 |
| 2026-10-12 | $3.79 | 3,400 |
| 2026-10-09 | $3.85 | 5,700 |
| 2026-10-08 | $3.81 | 0 |
| 2026-10-07 | $3.81 | 400 |
| 2026-10-06 | $3.78 | 4,800 |
| 2026-10-05 | $3.92 | 800 |
| 2026-10-02 | $3.91 | 0 |
| 2026-10-01 | $3.91 | 0 |
| 2026-09-30 | $3.91 | 1,800 |
| 2026-09-29 | $3.90 | 700 |
| 2026-09-28 | $3.86 | 2,300 |
About Molecular Partners AG
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
đ° Latest News
No news articles available at the moment. Check back later for updates on MOLN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $6,017,969 | $8,522,026 | $229,525,589 |
| Operating Revenue | $0 | $6,017,969 | $8,522,026 | $229,525,589 |
| Expenses | ||||
| Interest Expense | $21,795 | $30,271 | $41,169 | $732,570 |
| Total Expenses | $67,125,180 | $80,143,125 | $82,515,197 | $88,323,688 |
| Other Income Expense | $-9,326,036 | $4,637,590 | $-6,182,646 | $868,186 |
| Net Non Operating Interest Income Expense | $1,802,969 | $4,051,534 | $5,121,934 | $633,279 |
| Total Other Finance Cost | $18,163 | $15,741 | $18,163 | $16,952 |
| Interest Expense Non Operating | $21,795 | $30,271 | $41,169 | $732,570 |
| Operating Expense | $67,125,180 | $80,143,125 | $82,515,197 | $88,323,688 |
| General And Administrative Expense | $18,006,684 | $20,783,184 | $23,000,267 | $26,423,365 |
| Other Operating Expenses | - | - | - | $-53,278 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Net Interest Income | $1,802,969 | $4,051,534 | $5,121,934 | $633,279 |
| Interest Income | $1,842,927 | $4,097,547 | $5,181,266 | $1,382,801 |
| Normalized Income | $-67,153,468 | $-69,166,612 | $-70,064,489 | $142,003,608 |
| Net Income From Continuing And Discontinued Operation | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Total Operating Income As Reported | $-70,379,969 | $-74,125,155 | $-73,993,172 | $141,201,901 |
| Net Income Common Stockholders | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Net Income | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Net Income Including Noncontrolling Interests | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Net Income Continuous Operations | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Pretax Income | $-74,648,246 | $-65,436,031 | $-75,053,884 | $142,703,366 |
| Special Income Charges | $-3,256,000 | $0 | $0 | - |
| Interest Income Non Operating | $1,842,927 | $4,097,547 | $5,181,266 | $1,382,801 |
| Operating Income | $-67,125,180 | $-74,125,155 | $-73,993,172 | $141,201,901 |
| Depreciation Amortization Depletion Income Statement | $449,229 | $507,350 | $444,385 | $503,717 |
| Depreciation And Amortization In Income Statement | $449,229 | $507,350 | $444,385 | $503,717 |
| Per Share | ||||
| Diluted EPS | $-2.00 | $-1.93 | $-2.29 | $4.29 |
| Basic EPS | $-2.00 | $-1.93 | $-2.29 | $4.40 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,828,836 | $909,431 | $-1,193,251 | $168,428 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-62,704,333 | $-67,174,825 | $-65,899,790 | $145,459,281 |
| Total Unusual Items | $-9,326,036 | $4,637,590 | $-6,182,646 | $868,186 |
| Total Unusual Items Excluding Goodwill | $-9,326,036 | $4,637,590 | $-6,182,646 | $868,186 |
| Reconciled Depreciation | $2,596,082 | $2,868,525 | $2,930,279 | $2,891,531 |
| EBITDA (Bullshit earnings) | $-72,030,369 | $-62,537,235 | $-72,082,436 | $146,327,467 |
| EBIT | $-74,626,451 | $-65,405,760 | $-75,012,715 | $143,435,935 |
| Diluted Average Shares | $45,130,266 | $41,208,612 | $39,680,655 | $40,279,911 |
| Basic Average Shares | $45,130,266 | $41,208,612 | $39,680,655 | $39,316,540 |
| Diluted NI Availto Com Stockholders | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Tax Provision | $2,422 | $2,422 | $0 | $0 |
| Restructuring And Mergern Acquisition | $3,256,000 | $0 | $0 | - |
| Gain On Sale Of Security | $-6,070,036 | $4,637,590 | $-6,182,646 | $868,186 |
| Research And Development | $48,669,267 | $58,852,591 | $59,070,545 | $61,449,883 |
| Selling General And Administration | $18,006,684 | $20,783,184 | $23,000,267 | $26,423,365 |
| Other Gand A | $6,156,007 | $7,510,958 | $8,905,868 | $12,149,759 |
| Salaries And Wages | $11,850,677 | $13,272,225 | $14,094,399 | $14,273,606 |
Fetched: 2026-10-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $97,270,725 | $171,443,104 | $213,373,940 | $284,424,725 |
| Total Assets | $123,637,180 | $191,955,056 | $240,176,304 | $317,557,460 |
| Total Non Current Assets | $6,334,003 | $5,142,518 | $7,135,592 | $9,088,708 |
| Goodwill And Other Intangible Assets | $2,422 | $59,332 | $256,702 | $328,143 |
| Other Intangible Assets | $2,422 | $59,332 | $256,702 | $328,143 |
| Current Assets | $117,303,176 | $186,812,537 | $233,040,712 | $308,468,752 |
| Other Current Assets | $-1,211 | - | - | - |
| Prepaid Assets | $2,317,584 | $2,723,222 | $3,010,195 | $4,734,459 |
| Receivables | $2,306,686 | $3,139,757 | $3,734,289 | $2,056,039 |
| Other Receivables | $184,051 | $427,433 | $1,449,398 | $912,988 |
| Taxes Receivable | $1,816,288 | $2,366,018 | $1,927,688 | $512,193 |
| Accounts Receivable | $306,347 | $346,306 | $357,203 | $630,858 |
| Cash Cash Equivalents And Short Term Investments | $112,680,117 | $180,949,558 | $226,296,228 | $301,678,255 |
| Cash And Cash Equivalents | $100,081,129 | $77,342,408 | $81,501,708 | $106,490,206 |
| Cash Financial | $100,081,129 | $77,342,408 | $81,501,708 | $106,490,206 |
| Other Non Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $4,412,370 | $2,959,339 | $4,422,057 | $5,872,666 |
| Long Term Debt And Capital Lease Obligation | $2,952,074 | $1,485,724 | $2,959,339 | $4,422,057 |
| Current Debt And Capital Lease Obligation | $1,460,296 | $1,473,615 | $1,462,718 | $1,450,609 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $26,364,033 | $20,452,619 | $26,545,662 | $32,804,592 |
| Total Non Current Liabilities Net Minority Interest | $13,011,891 | $7,393,505 | $9,089,919 | $11,916,063 |
| Other Non Current Liabilities | $1,211 | - | - | - |
| Tradeand Other Payables Non Current | $193,737 | $0 | - | - |
| Current Liabilities | $13,352,142 | $13,059,114 | $17,455,743 | $20,888,529 |
| Other Current Liabilities | $1,211 | - | - | - |
| Payables And Accrued Expenses | $11,890,635 | $11,585,499 | $10,746,374 | $11,677,524 |
| Payables | $2,138,377 | $2,250,987 | $1,608,021 | $2,594,871 |
| Other Payable | $1,003,802 | $1,428,814 | $1,111,569 | $1,387,644 |
| Accounts Payable | $1,134,575 | $822,173 | $496,452 | $1,207,226 |
| Current Deferred Liabilities | - | $0 | $5,246,652 | $7,760,395 |
| Non Current Deferred Liabilities | - | - | $0 | $4,403,894 |
| Total Tax Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $97,273,147 | $171,502,436 | $213,630,643 | $284,752,868 |
| Total Equity Gross Minority Interest | $97,273,147 | $171,502,436 | $213,630,643 | $284,752,868 |
| Stockholders Equity | $97,273,147 | $171,502,436 | $213,630,643 | $284,752,868 |
| Retained Earnings | $-377,488,926 | $-298,226,096 | $-232,188,268 | $-154,723,563 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $-1,187,853 |
| Other Equity Adjustments | - | - | - | $-1,187,853 |
| Other | ||||
| Treasury Shares Number | $3,587,743 | $4,238,006 | $4,238,006 | - |
| Ordinary Shares Number | $45,300,255 | $44,636,010 | $39,781,921 | $43,645,057 |
| Share Issued | $48,887,997 | $48,874,017 | $44,019,928 | $43,645,057 |
| Tangible Book Value | $97,270,725 | $171,443,104 | $213,373,940 | $284,424,725 |
| Invested Capital | $97,273,147 | $171,502,436 | $213,630,643 | $284,752,868 |
| Working Capital | $103,951,034 | $173,753,423 | $215,584,969 | $287,580,223 |
| Capital Lease Obligations | $4,412,370 | $2,959,339 | $4,422,057 | $5,872,666 |
| Total Capitalization | $97,273,147 | $171,502,436 | $213,630,643 | $284,752,868 |
| Treasury Stock | $1,367,060 | $1,187,853 | $1,187,853 | $1,187,853 |
| Additional Paid In Capital | $471,240,895 | $466,029,358 | $442,605,290 | $436,300,347 |
| Capital Stock | $4,888,238 | $4,887,027 | $4,401,472 | $4,363,936 |
| Common Stock | $4,888,238 | $4,887,027 | $4,401,472 | $4,363,936 |
| Employee Benefits | $9,864,868 | $5,907,781 | $6,130,579 | $3,090,112 |
| Long Term Capital Lease Obligation | $2,952,074 | $1,485,724 | $2,959,339 | $4,422,057 |
| Current Capital Lease Obligation | $1,460,296 | $1,473,615 | $1,462,718 | $1,450,609 |
| Current Accrued Expenses | $9,752,258 | $9,334,512 | $9,138,353 | $9,082,653 |
| Net PPE | $6,331,582 | $5,083,186 | $6,878,890 | $8,760,565 |
| Accumulated Depreciation | $-24,064,612 | $-22,116,340 | $-19,787,858 | $-17,795,995 |
| Gross PPE | $30,396,193 | $27,199,526 | $26,666,748 | $26,556,560 |
| Leases | $766,474 | $766,474 | $766,474 | $755,576 |
| Other Properties | $27,404,161 | $23,754,632 | $23,437,387 | $11,679,946 |
| Machinery Furniture Equipment | $2,225,559 | $2,678,420 | $2,462,887 | $14,121,038 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $12,598,988 | $103,607,150 | $144,794,519 | $195,188,049 |
| Current Deferred Revenue | - | $0 | $5,246,652 | $7,760,395 |
| Non Current Deferred Revenue | - | - | $0 | $4,403,894 |
Fetched: 2026-10-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-62,929,553 | $-72,616,425 | $-72,425,109 | $141,850,921 |
| Operating Activities | ||||
| Operating Cash Flow | $-62,065,000 | $-71,740,974 | $-71,446,735 | $143,566,708 |
| Cash Flow From Continuing Operating Activities | $-62,062,578 | $-71,740,974 | $-71,446,735 | $143,566,708 |
| Operating Gains Losses | $-661,129 | $-811,276 | $647,810 | $1,388,855 |
| Investing Activities | ||||
| Capital Expenditure | $-864,553 | $-875,451 | $-978,374 | $-1,715,787 |
| Investing Cash Flow | $87,846,610 | $49,022,837 | $54,049,113 | $-122,443,273 |
| Cash Flow From Continuing Investing Activities | $87,846,610 | $49,022,837 | $54,049,113 | $-122,443,273 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $20,998,717 | $0 | $0 |
| Financing Cash Flow | $-1,391,277 | $17,476,328 | $-1,413,072 | $-1,901,049 |
| Cash Flow From Continuing Financing Activities | $-1,391,277 | $17,476,328 | $-1,413,072 | $-1,901,049 |
| Net Common Stock Issuance | $0 | $20,998,717 | $0 | $-764,052 |
| Common Stock Issuance | $0 | $20,998,717 | $0 | $0 |
| Repurchase Of Capital Stock | - | $0 | $0 | $-764,052 |
| Net Other Financing Charges | - | $-2,108,106 | - | - |
| Other | ||||
| Repayment Of Debt | $-1,467,561 | $-1,462,718 | $-1,450,609 | $-1,439,711 |
| End Cash Position | $100,081,129 | $77,342,408 | $81,501,708 | $106,490,206 |
| Beginning Cash Position | $77,342,408 | $81,501,708 | $106,490,206 | $86,955,417 |
| Effect Of Exchange Rate Changes | $-1,651,612 | $1,082,508 | $-6,177,803 | $312,402 |
| Changes In Cash | $24,390,333 | $-5,241,809 | $-18,810,695 | $19,222,387 |
| Proceeds From Stock Option Exercised | $76,284 | $48,434 | $37,537 | $302,715 |
| Net Issuance Payments Of Debt | $-1,467,561 | $-1,462,718 | $-1,450,609 | $-1,439,711 |
| Net Long Term Debt Issuance | $-1,467,561 | $-1,462,718 | $-1,450,609 | $-1,439,711 |
| Long Term Debt Payments | $-1,467,561 | $-1,462,718 | $-1,450,609 | $-1,439,711 |
| Interest Received Cfi | $2,091,153 | $5,132,831 | $4,633,957 | $598,164 |
| Net Investment Purchase And Sale | $86,620,009 | $44,765,457 | $50,393,530 | $-121,325,650 |
| Sale Of Investment | $166,873,322 | $335,426,106 | $386,800,432 | $241,226,119 |
| Purchase Of Investment | $-80,253,313 | $-290,660,649 | $-336,406,902 | $-362,551,769 |
| Net Intangibles Purchase And Sale | $0 | $-21,795 | $-282,130 | $-290,606 |
| Purchase Of Intangibles | $0 | $-21,795 | $-282,130 | $-290,606 |
| Net PPE Purchase And Sale | $-864,553 | $-853,656 | $-696,244 | $-1,425,181 |
| Purchase Of PPE | $-864,553 | $-853,656 | $-696,244 | $-1,425,181 |
| Interest Paid Cfo | $-21,795 | $-31,482 | $-41,169 | $-782,215 |
| Change In Working Capital | $1,465,139 | $-4,597,632 | $-7,277,263 | $-7,277,263 |
| Change In Other Working Capital | $-21,795 | $-5,293,876 | $-6,943,066 | $-30,620,202 |
| Change In Other Current Assets | $405,638 | $286,974 | $1,724,263 | $2,163,805 |
| Change In Payables And Accrued Expense | $494,030 | $829,438 | $-928,729 | $-9,412,007 |
| Change In Accrued Expense | $415,325 | $194,948 | $54,489 | $-2,947,231 |
| Change In Payable | $78,706 | $634,490 | $-983,218 | $-6,464,776 |
| Change In Receivables | $587,267 | $-420,168 | $-1,129,731 | $30,591,142 |
| Other Non Cash Items | $3,854,164 | $-8,703,654 | $1,042,550 | $-1,518,417 |
| Stock Based Compensation | $5,350,786 | $4,970,576 | $6,304,943 | $6,160,851 |
| Deferred Tax | $2,422 | $2,422 | $0 | $0 |
| Deferred Income Tax | $2,422 | $2,422 | $0 | $0 |
| Depreciation Amortization Depletion | $2,596,082 | $2,868,525 | $2,930,279 | $2,891,531 |
| Depreciation And Amortization | $2,596,082 | $2,868,525 | $2,930,279 | $2,891,531 |
| Amortization Cash Flow | $55,700 | $219,165 | $353,571 | - |
| Amortization Of Intangibles | $55,700 | $219,165 | $353,571 | - |
| Depreciation | $2,539,171 | $2,649,359 | $2,576,708 | - |
| Pension And Employee Benefit Expense | $-661,129 | $-811,276 | $647,810 | $1,388,855 |
| Net Income From Continuing Operations | $-74,650,668 | $-65,438,453 | $-75,053,884 | $142,703,366 |
| Common Stock Payments | - | $0 | $0 | $-764,052 |
| Taxes Refund Paid | - | $0 | $0 | $0 |
| Change In Account Payable | - | $634,490 | $-983,218 | $-6,464,776 |
| Change In Prepaid Assets | - | - | - | - |
Fetched: 2026-10-21